Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
157 studies found for:    caregivers and alzheimer's | United States, Florida
Show Display Options
Rank Status Study
1 Completed Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
2 Completed Coordinating Center for Caregiver Intervention Trial
Conditions: Dementia;   Alzheimer Disease
Interventions: Behavioral: multicomponent psychosocial intervention;   Other: Control arm
3 Recruiting Powerful Tools for Caregivers of Dementia Patients
Conditions: Caregivers;   Dementia;   Alzheimer Disease
Interventions: Behavioral: Powerful Tools for Caregivers;   Other: Control with delayed intervention
4 Completed
Has Results
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Dementia of the Alzheimer's Type
Interventions: Drug: memantine ER;   Drug: Placebo
5 Recruiting Caregiver Burden and Depression: Caring for Those Who Care for Others
Conditions: Dementia;   Alzheimer's Disease
Interventions: Behavioral: UCF Caregiver Support Group;   Behavioral: Community Support Groups
6 Completed Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone Extended Release 2mg;   Drug: Rosiglitazone Extended Release 8mg;   Other: Placebo;   Other: Donepezil;   Other: Galantamine;   Other: Rivastigmine
7 Completed Coordinating Center for Enhancing ADRD Caregiving
Conditions: Dementia;   Alzheimer Disease
Interventions: Procedure: Skill Training Condition – problem solving training;   Procedure: REACH for TLC (Telephone Linked Computer) system
8 Completed
Has Results
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol;   Drug: Memantine;   Drug: Placebo
9 Completed Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
10 Terminated Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: EVP-6124
11 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
12 Completed Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894;   Drug: placebo (for SAR110894);   Drug: Donepezil
13 Recruiting Efficacy, Safety and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Interventions: Drug: AVP-786;   Drug: Placebo
14 Recruiting Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Interventions: Drug: AVP-786;   Drug: Placebo
15 Terminated
Has Results
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Dimebon 20 mg po TID;   Drug: Placebo po TID
16 Completed Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone
17 Terminated
Has Results
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
18 Terminated
Has Results
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
19 Terminated
Has Results
Phase 3 IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution;   Biological: Human albumin 0.25%
20 Completed ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
Condition: Alzheimer's Disease
Intervention: Drug: VP4896

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years